March 20, 2025 - 02:28
CHANDLER, Ariz., March 19, 2025 — Microchip Technology Incorporated, a prominent player in the embedded control solutions market, has announced an ambitious underwritten public offering. The company plans to raise approximately $1.35 billion through the issuance of depositary shares, each representing a 1/20th interest in a newly issued Series A Mandatory Convertible Preferred Stock.
This strategic move reflects Microchip's commitment to enhancing its capital structure and supporting future growth initiatives. The Series A Mandatory Convertible Preferred Stock is expected to attract a wide range of investors seeking stable returns and a stake in the company’s ongoing success.
The offering is anticipated to bolster Microchip's financial flexibility, enabling the company to invest in innovative technologies and expand its market presence. As the demand for smart and connected solutions continues to rise, Microchip aims to leverage this funding to accelerate its development efforts and maintain its competitive edge in the industry.
June 7, 2025 - 20:23
Yageo Corp. to Retain Shibaura's AI Technology in Japan Following AcquisitionTaiwan`s Yageo Corp. has announced its intention to maintain the advanced artificial intelligence technology of Shibaura Electronics Co. in Japan, contingent upon a successful acquisition of the...
June 7, 2025 - 00:28
Pankaj K. Jha Awarded NSF Grant for Quantum Technology ResearchPankaj K. Jha, a prominent professor in the field of quantum technology, has recently been awarded a significant grant from the National Science Foundation (NSF) to further his research on...
June 6, 2025 - 01:39
Utilizing Smart Manufacturing Technology for the Next Generation of CNC MachinistsIn an era marked by rapid technological advancements, the manufacturing industry faces a pressing challenge: bridging the skills gap in the workforce. As smart manufacturing technologies continue...
June 5, 2025 - 09:18
FDA Greenlights Innovative AI Tool for Enhanced Breast Cancer DetectionA groundbreaking development in breast cancer detection has received approval from the FDA. This new AI technology, created by a pioneering tech company, marks the first instance of an FDA-approved...